Botulinum toxin type A inhibits microglia pyroptosis by suppressing Cblb-mediated degradation of Pdlim1 to attenuate neuropathic pain
Abstract Background Microglia pyroptosis, a newly identified form of inflammatory cell death, is involved in the development of neuropathic pain (NP). Botulinum toxin type A (BTX-A) has been shown to be effective in relieving NP, but the mechanisms involved have not been clarified. Methods A mice mo...
Saved in:
| Main Authors: | Sheng Tian, Lanxiang Wu, Heqing Zheng, Zhijuan Cheng, Jingjing Liu, Mingxu Liu, Xinping Yu, Jianglong Tu, Wei Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | The Journal of Headache and Pain |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10194-025-02109-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Co‐recruitment analysis of the CBL and CBLB signalosomes in primary T cells identifies CD5 as a key regulator of TCR‐induced ubiquitylation
by: Guillaume Voisinne, et al.
Published: (2016-07-01) -
WTAP modulates macrophage polarization in rheumatoid arthritis by targeting exosomal circ-CBLB via m6A modification
by: Dawei Yan, et al.
Published: (2025-06-01) -
Botulinum toxin type A for amyotrophic lateral sclerosis lower limb spasm: two case reports
by: Qiang Duan, et al.
Published: (2025-07-01) -
Exosome circ-CBLB promotes M1 macrophage polarization in rheumatoid arthritis through the TLR3/TRAF3 signaling axis
by: Mengyu Zhang, et al.
Published: (2025-07-01) -
Effects of botulinum toxin type A on the masseter muscles of a patient with a temporomandibular joint disorder of muscular origin: A case report
by: Mohammad Nasoh Alzaeem, et al.
Published: (2025-03-01)